[go: up one dir, main page]

Gagliardi, 2023 - Google Patents

Advanced Industrial and Engineering Polymer Research

Gagliardi, 2023

View PDF
Document ID
6869628188506648303
Author
Gagliardi M
Publication year

External Links

Snippet

abstract Polymer-based drug delivery systems have been extensively studied for decades. These systems must be degradable, capable of controlling drug release kinetics, and of reaching a precise target organ. While degradability is an intrinsic property of the material …
Continue reading at iris.cnr.it (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48876—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a solid micro- or nanoparticle having no hollow or gas-filled core
    • A61K47/48884—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a solid micro- or nanoparticle having no hollow or gas-filled core the form being a nanoparticle, e.g. an immuno-nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48169—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
    • A61K47/48176—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly(meth)acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/30—Macromolecular compounds
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein

Similar Documents

Publication Publication Date Title
Sung et al. Recent advances in polymeric drug delivery systems
Li et al. pH-Sensitive nanogels for drug delivery in cancer therapy
Cai et al. Design and development of hybrid hydrogels for biomedical applications: Recent trends in anticancer drug delivery and tissue engineering
Sikdar et al. Recent advances in the synthesis of smart hydrogels
Gopi et al. Biopolymers and their composites for drug delivery: a brief review
Jia et al. Preparation of dual-template epitope imprinted polymers for targeted fluorescence imaging and targeted drug delivery to pancreatic cancer BxPC-3 cells
Smeets et al. Designing responsive microgels for drug delivery applications
Webber Engineering responsive supramolecular biomaterials: Toward smart therapeutics
Chouhan et al. Real time in vitro studies of doxorubicin release from PHEMA nanoparticles
Islam et al. Responsive polymers for biosensing and protein delivery
Sonker et al. Review of recent advances and their improvement in the effectiveness of hydrogel-based targeted drug delivery: A hope for treating cancer
Culver et al. A closer look at the impact of molecular imprinting on adsorption capacity and selectivity for protein templates
Khutoryanskiy et al. Temperature-responsive polymers
Hu et al. Recent advances in smart‐responsive hydrogels for tissue repairing
Rostami Recent achievements in sodium alginate-based nanoparticles for targeted drug delivery
CN101045033B (en) A polysaccharide-modified acid-sensitive nanogel
Yin et al. Sialic acid-imprinted mesoporous nanocarriers for tumor cell targeted drug delivery
Sharma et al. Selection and role of polymers for designing of a drug carrier
Hocine et al. Synthesis, characterization and swelling behavior of pH-sensitive polyvinylalcohol grafted poly (acrylic acid-co-2-acrylamido-2-methylpropane sulfonic acid) hydrogels for protein delivery
Mueller et al. Cationic, anionic, and amphoteric dual pH/temperature-responsive degradable microgels via self-assembly of functionalized oligomeric precursor polymers
Morishita et al. Molecularly imprinted nanogels possessing dansylamide interaction sites for controlling protein corona in situ by cloaking intrinsic human serum albumin
Zhang et al. Abiotic mimic of matrix metalloproteinase-9 inhibitor against advanced metastatic cancer
Singh et al. Poly (Oligo (Ethylene Glycol) Methacrylate)-Based Polymers in Biomedical Applications: Preparation and Applications
López‐Iglesias et al. Rational Design and Development of Polymeric Nanogels as Protein Carriers
Heggannavar et al. Smart polymers in drug delivery applications